People living with one of the most common types of alopecia could soon have access to treatment on the NHS in Scotland for the first time.

The drug – called Ritlecitinib – will go before the Scottish Medicines Consortium this week after it was approved for NHS use in England last month.

Although the daily pill won’t cure the condition, it could provide treatment to some who have severe alopecia areata, like 21-year-old Megan McCready, from Clydebank.

Since her diagnosis at the age of 12, Megan has learned to embrace her condition and now supports other young people going through the same thing.

Video by Morgan Spence and Hazel Martin



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Fat-rich fluid fuels immune failure in ovarian cancer

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian

Vitamin D builds your bones and keeps your gut sealed, among many other essential functions − but many children are deficient

You’ve likely heard about vitamin D’s important role in maintaining strong bones and teeth. But it also plays several other important roles to keep your body healthy – including the

Sliced Bread

Can standing desks help relieve muscle tension, back pain, and reduce stress? Source link